Acarix AB (publ) (STO:ACARIX)

Market Cap	309.81M +16.7%
Revenue (ttm)	7.36M +18.7%
Net Income	-48.09M
EPS	-0.04
Shares Out	1.16B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,886,292
Average Volume	1,596,105
Open	0.2755
Previous Close	0.2840
Day's Range	0.2600 - 0.2790
52-Week Range	0.1914 - 0.4710
Beta	-0.30
RSI	41.11
Earnings Date	Feb 12, 2026

About Acarix AB

Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 8
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ACARIX

Financial Performance

In 2025, Acarix AB's revenue was 7.36 million, an increase of 18.69% compared to the previous year's 6.20 million. Losses were -48.09 million, -27.34% less than in 2024.